Polyomavirus small t antigen was purified from genetically engineered Escherichia coli and used as the immunogen for the production of polyclonal and monoclonal antibodies. A new series of plasmids for increased expression of polyomavirus T antigens or a T antigen--galactosidase fusion protein was constructed by replacing sequences coding for the ribosome-binding site of previously published plasmids with a chemically synthesized sequence that has a higher degree of complementarity to the 3' end of the 16S rRNA. Cells expressing the fusion protein from the plasmid with the synthetic sequence contained 5-to 10-fold more fusion protein after a 3-h induction than did control cells. Pulse-labeling of cells bearing the new plasmids revealed that the T antigens were synthesized at high levels after induction: 10% of total synthesis for small t; 15% for Py-1387T middle T, a truncated mutant of middle T; and probably 1 to 5% for middle T. Small t and Py-1387T middle T, but not wild-type middle T, were seen as minor bands in total cell protein analyzed on sodium dodecyl sulfate-polyacrylamide gels stained with Coomassie blue. A simple, rapid procedure for purification of bacterial small t from the pellet of sonicated bacteria yielded 1 to 2 mg of small t per liter of bacterial culture at 80 to 90% homogeneity. High-titer polyclonal rabbit antisera raised against purified small t recognized all three T antigens and were suitable for immunoaffinity purification of middle T. Mouse monoclonal antibodies raised against bacterial small t were of four classes, immunoprecipitating either (i) all three polyomavirus T antigens, (ii) small t and middle T only, (iii) primarily small t, or (iv) middle T and large T in preference to small t. One of the latter monoclonal antibodies also immunoprecipitated large T but not small t of simian virus 40, suggesting that the site recognized by this antibody may be functionally important. None of the monoclonal antibodies yielded an immunoprecipitate active in phosphorylating middle T in vitro.
The three polyomavirus early gene products are called large, middle, and small tumor (T) antigens according to their respective sizes of 100, 56, and 22 kilodaltons (kDa) (see reference 42 for a review). They function as an ensemble in the lytic growth of the virus and in transformation. All three T antigens share a common amino-terminal sequence of 79 amino acids, and small t and middle T share an additional 112 amino acids. The large, middle, and small T antigens possess unique carboxy-terminal sequences of 706, 230, and 4 amino acids, respectively. Large T antigen has an origin-specific DNA-binding activity as well as an ATPase activity (42) . Middle T antigen has an associated tyrosine kinase activity (14, 34, 40) resulting from the formation of a complex with pp60c-src (5, 10, 11) . It also has associated phospholipid kinase activity (24, 46) . Small t, however, has no known intrinsic or associated biochemical activity. Moreover, whereas middle T will transform established rodent cell lines (30) and large T will immortalize primary rodent fibroblasts which can be subsequently transformed by middle T (31) , small t function in vivo is measurable only by rather difficult assays. Small t can complement middle T to cause tumor formation in animals (1, 2) . At least when large T is also expressed, it is able to bring about the increase in lectin agglutinability that is observed for polyomavirusinfected NIH 3T3 cells (26) . More recently, some of us, and Ito and colleagues as well, have shown that the introduction * Corresponding author.
of the gene coding for small t into fibroblasts by a retrovirus vector markedly changes their growth properties (9; Y. Ito, personal communication) .
The study of the T antigens has been greatly facilitated by various monoclonal and polyclonal antibodies. Anti-T rat ascites antisera or hamster antisera raised against polyomavirus-transformed cells have been used frequently but presumably recognize cellular antigens in addition to the T antigens. Two approaches have heretofore been taken to obtain antibodies specific for individual T antigens. Monoclonal antibodies have been raised (4, 13) that recognize all three T antigens or are specific for middle T or for large T, but none has been produced that is specific for small t. Rabbit antipeptide sera have also been raised and have proven useful for identifying proteins that may interact with middle T in vivo (22, 23, 36, 43, 44) . However, antisera for immunoaffinity purification of small and large T antigens are not readily available.
We have undertaken the overproduction and purification of the T antigens to provide an abundant source of the proteins for biochemical studies of their function and for immunization to generate more immunological reagents to aid in these analyses. The three products of the early region of polyomavirus have previously been cloned for expression in Escherichia coli by using the tac promoter (35) . Here we report the construction of a new ribosome-binding site which significantly increases expression of T antigens in E. coli. A simple method to purify small t in milligram quantities is described that provided small t for the production of polyclonal and monoclonal antibodies. Among the monoclonal antibodies obtained were two that prefer to bind small t. Analysis of the monoclonal antibodies revealed antigenic differences among the three T antigens which must be localized to the 79 amino acids common to all three proteins. Interestingly, none of the monoclonal antibodies recognizing middle T is effective in immunoprecipitating the kinaseactive middle T-pp60c-sc complex. Potential implications of these results are discussed.
MATERIALS AND METHODS Plasmid constructions. All plasmid constructions were performed by standard procedures (27) . pTR1300 was constructed from our previously published plasmid pTR1070 (35) as follow.: pTR1070 was cut with BclI and PstI, and the large backbone fragment was isolated. Since the PstI site is in the P-lactamase gene and the Bcll site is immediately 5' to the ATG initiator codon for the polyomavirus-lacZ fusion gene, this large fragment is missing part of the ,-lactamase gene and both the promoter and Shine-Dalgarno sequence for the fusion protein expression. These elements were replaced by ligating into place two fragments: (i) a PstI-toXbaI fragment containing the missing portion of the Ilactamase gene and a tac promoter (the same PstI-to-PvuII fragment which was used in our earlier work [35] , modified with the addition of an XbaI linker to its PvuII end) and (ii) a chemically synthesized Shine-Dalgarno fragment with an XbaI sticky end upstream and a GATC sticky end downstream. The remaining constructions were generated from pTR1300 by using the methods previously described (35 (4) . All hybridoma cell lines were grown in DMEM supplemented with 10% fetal bovine serum.
Wild-type polyomavirus NG59RA was derived from NG59 by marker rescue (15) , and stocks were prepared on 3T6 cells. Plaque assays were on mouse UC1-B cells (19) . Polyomavirus infections of subconfluent 3T6 cells were at 10 PFU per cell.
Antisera. Anti-T ascites fluid from Brown Norwegian rats bearing mixed solid-ascites polyomavirus tumors was described previously (37) . An anti-bacterial protein monoclonal antibody supernatant was used as a control in immunoprecipitations. PAb419 (21) , an anti-SV40 T antigen monoclonal antibody, recognizes both small and large T antigens of SV40.
Bacterial cell culture for protein production. (i) For production of fusion protein. E. coli X90 cells were transformed with pTR1070 (35) or pTR1300 (see Fig. 1B ), and colonies were selected on Luria broth (LB; 27) ampicillin plates. Fresh colonies were each inoculated into 5 ml of TBYE (10 g of tryptone, 1 g of yeast extract, and 5 g of NaCl per liter) plus ampicillin and grown overnight. These overnight cultures were in turn inoculated into LB plus ampicillin at a 1:50 dilution, and the cells were grown to an optical density at 550 nm (OD550) of =0.25. The cultures were divided into two tubes, and one tube of each pair was induced with 5 mM isopropyl-p-D-thiogalactopyranoside (IPTG; final concentration). After 3 h at 37°C, the cells were collected by centrifugation at 13 ,000 x g, boiled in sample buffer, and analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis.
(ii) For optimal production of small t and Py-1387T middle T, a truncated (51,000-molecular-weight) mutant of middle T lacking the membrane anchoring sequence (7) . E. coli PR13Q cells were transformed with pTR1330 or pTR1340A (see Fig.  1B ), and colonies were selected on LB ampicillin or LB tetracycline plates, respectively. Fresh colonies were inoculated into TBYE plus the appropriate drug (1 colony per 50 ml of culture) and grown overnight. These cultures were in turn inoculated into LB with the appropriate drug at a 1:10 dilution. Cells were grown to an OD550 of -0.25 (-1 h), induced with 0.5 to 5 mM IPTG, and grown at 37°C for 3 h (small t) or for 2 h (Py-1387T middle T). The final OD550 was usually in the range of 0.75 to 1.5.
Purification of insoluble small t and Py-1387T middle T from bacteria. For purification of small t or Py-1387T middle T, cells were collected by centrifugation, resuspended in 10 times the cell pellet volume of bacterial lysis buffer (25 mM Tris hydrochloride, pH 8.4, containing 0.02 trypsin inhibitor units of aprotinin [Sigma Chemical Co.] per ml and 1 mM phenylmethylsulfonyl fluoride), and thoroughly sonicated. Sonication was performed on 10-ml portions contained in 50-ml disposable centrifuge tubes (Becton Dickinson Labware) by using a Sonifier Cell Disrupter 200 microtip (Branson Sonic Power Co.). Complete cell lysis was obtained by sonicating for six 45-s periods on ice at a power setting of >4, cooling the tip after each period. The sonicated suspension was transferred to Eppendorf tubes, and insoluble material (enriched for small t, Py-1387T middle T, or ElA) was collected by centrifugation for 5 min at 13,000 x g. The pelleted material was washed with (i) lysis buffer, (ii) lysis buffer containing 1% Nonidet P-40 (NP-40)-2 mM P-mercaptoethanol, and finally (iii) lysis buffer containing 2 M NaCl-2 mM ,-mercaptoethanol. For each wash, the pellets from 10 ml of original suspension were resuspended in 10 ml of the appropriate buffer, sonicated for 1 min, and then centrifuged again at 13,000 x g in Eppendorf tubes.
Metabolic labeling of T antigens. (i) Bacteria. Cultures grown at 37°C overnight in TBYE plus the appropriate drug were inoculated at a dilution of 1:20 into M9CA medium (27) and grown at 30°C. At an OD550 of --0.25, the cells were pelleted and resuspended in one-fifth the original volume of labeling medium (identical to M9CA medium, except containing only 0.0025% Casamino Acids [Difco Laboratories], MgCl instead of MgSO4, 20 jig of leucine per ml, 5 mM IPTG, and 10 to 50 ,uCi of [35S]methionine per ml). After 10 min of incubation at 30°C, the cells were pelleted, boiled in sample buffer, and analyzed by SDS-polyacrylamide gel electrophoresis.
(ii) Eucaryotic cells. Polyomavirus-infected 3T6 cells were labeled beginning 20 (29) .
Immunization of rabbits with bacterial small t. Rabbits were immunized with SDS-polyacrylamide gel bands con- taining bacterial small t. Rabbits were bled 14 days before the initial injection. The initial injection was made intramuscularly with -0.5 mg of small t in an unfixed gel band by using a gel band/phosphate-buffered saline (PBS)/Freund complete adjuvant ratio of 3:1:4 (vol/vol/vol). The second injection, made subcutaneously 2 weeks later, was similar except that Freund incomplete adjuvant was used. The third and following injections were made after 16-to 18-day intervals subcutaneously without Freund adjuvant, with -0.1 to 0.4 mg per rabbit. Immune sera were first collected after five injections. Rabbits were bled (up to 40 ml per rabbit) at 6 to 8 days after the previous injection and were given >10 days of recovery between a bleed and a subsequent injection.
Production of monoclonal antilodies. BALB/c female mice were immunized with purified bacterial small t in 0.1% SDS. The initial intraperitoneal (i.p.) injection (day 0) was mixed 1:1 with Freund complete adjuvant, but subsequent i.p. injections on days 7, 28, 49, and 63 were mixed with Freund incomplete adjuvant. All i.p. injections through day 49 were 100 pLg of small t per mouse. On day 63, the mice received either 100 ,ug of small t i.p., 50 ,ug of small t i.p., or 50 jxg of small t both i.p. and intravenously in the tail vein (mouse 4). Intravenous injections were done with purified protein in PBS (150 mM NaCl, 10 mM sodium phosphate, pH 7.2) made 0.1% in SDS. Test bleeds were obtained after each injection and assayed by immunoprecipitation for the presence of anti-small t antibodies. On day 66, mouse 4 was sacrificed by cervical dislocation, its spleen was removed, and the splenocytes were washed in DMEM. Fusion of the splenocytes with the NS-1 myelomas was accomplished with polyethylene glycol by using standard techniques (17) . The cells were then washed in DMEM and resuspended in DMEM containing 20% fetal bovine serum, 0.15 mg of oxalacetate per ml, 0.05 mg of sodium pyruvate per ml, and 0.2 U of insulin per ml. In addition, 1 ,ug of azaserine per ml and 0.1 mM hypoxanthine were provided in order to select for the B cell hybridomas, based on results obtained by Foung et al. (16) when preparing T cell hybridomas. The cells were then plated into 2,000 microtiter wells, and supematants from colony-producing wells were screened after 10 to 14 days by solid-phase radioimmunoassay (see below) for the presence of antibodies to bacterial small t. All hybrids were single-cell cloned, again screening with the radioimmunoassay for purified bacterial small t.
Radioimmunoassay for screening monoclonal supernatants. Small t (10 ,ug) in PBS was bound to a sheet (7 by 11 cm) of nitrocellulose by incubation for at least 1 h at room termperature. Remaining sites on the nitrocellulose were then blocked by incubating the sheet in 3% bovine serum albumin in PBS for about 2 h at room temperature. The blocked paper could then be stored or processed further. Approximately 1 ,ul of supernatant from each clone was spotted onto the nitrocellulose and allowed to incubate for 30 min at room temperature, after which time the sheet was extensively washed in 150 mM NaCl-5 mM EDTA-0.25% gelatin-0.02% NaN3-0.05% NP-40-50 mM Tris, pH 7.5 (NET/GEL). The paper was then probed with '25I-rabbit anti-mouse immunoglobulin (2.5 x 10' cpm) for Electrophoresis and fluorography. Proteins were analyzed on 7.5, 10, or 15% SDS-polyacrylamide gels (25) . Fluorography was performed with En3Hance (New England Nuclear Corp.). Films (XAR-5; Eastman Kodak Co.) were exposed at -70°C.
RESULTS
Enhanced production of T antigens in bacteria. (i) Construction of an improved ribosome-binding site. The production of the three wild-type polyomavirus T antigens, Py-1387T middle T antigen, and a T antigen-p-galactosidase fusion protein in E. coli has been reported previously (35) . In those plasmids, transcription of these proteins was directed by the strong tac promoter, and translation of the resulting mRNAs was facilitated by a hybrid ribosome-binding site formed from the Shine-Dalgarno sequence (20, 39, 41) of the lacZ gene and the initiator AUG common to all three T antigens. The Shine-Dalgarno sequence is a run of bases in the 5' untranslated leader which is complementary to the 3' end of the 16S rRNA. This complementarity is thought to aid binding of mRNA to ribosomes.
To enhance protein production, we substituted for the lac Shine-Dalgarno sequence a chemically synthesized ShineDalgarno sequence that features a much longer run of bases complementary to the 16S rRNA. The resulting plasmids differ from their corresponding predecessors only in the sequences coding for the 5' untranslated regions of the T antigen mRNAs (Fig. 1A) . This provides a series of plasmids (1300 series; Fig. 1B pTR1340, which direct synthesis of middle T, small t, and Py-1387T middle T, respectively (see Fig. 1 pTR1340A (B) , which direct the synthesis of small t and Py-1387T middle T, respectively (see Fig. 1 ), were grown, and expression was induced as described in Materials and Methods. Cells collected by centrifugation were resuspended in 25 mM Tris (pH 8.4) and thoroughly sonicated, and the sonicated material was centrifuged at 13,000 x g. The pelleted material was washed as described in Materials and Methods. The small t-or Py-1387T middle T-containing pellets obtained after initial sonication (lanes 1), after the wash with lysis buffer (lanes 2), after the wash with lysis buffer containing 1% NP-40 and 2 mM ,3-mercaptoethanol (lanes 3), and after the wash with lysis buffer containing 2 M NaCl and 2 mM P-mercaptoethanol (lanes 4 moter is not completely shut off in these cells in the absence of inducer. Here again, the uninduced level of fusion protein is higher in cells bearing pTR1300 than in cells bearing pTR1070.
(iii) Measurement of the levels of production of small and middle T antigens from plasmids with the synthetic ShineDalgarno sequence. Pulse-labeling of cells transformed by plasmids in which the construction with the synthetic ShineDalgarno sequence drives the production of intact T antigens reveals that these proteins can be a significant fraction of the total protein being translated upon induction. Figure 3 shows representative SDS-polyacrylamide gel electrophoresis profiles of pulse-labeled proteins from PR13Q cells containing plasmids pTR1320A, pTR1330, and pTR1340 that direct synthesis of middle T, small t, and Py-1387T middle T, respectively. By laser densitometric scanning of these autoradiographs, we estimate the percentage of total protein label residing in the T antigen to be 10% for small t and 15% for Py-1387T middle T. It is difficult to estimate the percentage of label found in middle T since it is observed as a darkening of comigrating bands, but it is probably less than 5%. These percentages vary for different experiments and for different colonies picked from the same transformation and labeled in the same experiment. Small t labeling is the most consistent, and labeling of middle T is more variable. In comparison, under comparable labeling conditions with the previously published constructs, small t and Py-1387T middle T were detectable at much lower levels and middle T was never seen (35) .
The amount of the various T antigens which actually accumulates in cells after induction is much less than might be anticipated from either the initial rate of synthesis indicated by the levels of the pulse-labeled proteins or the amount of 13-galactosidase fusion protein that accumulated.
Small t can be seen in whole-cell extracts analyzed on 15% SDS-polyacrylamide gels and stained with Coomassie blue (data not shown). However, it is only a minor band comprising not more than a few tenths of one percent of total protein. Py-1387T middle T can be seen at a similar level to small t in whole-cell extracts analyzed on 10% gels but only as an increase in Coomassie blue staining of a 51-kDa cellular band (data not shown). Wild-type middle T cannot be seen by staining without immunoaffinity purification. With the previously published constructs, none of these proteins could be detected in whole-cell extracts analyzed similarly.
Purification of small t from pellets of sonicated bacteria producing small t. As is the case for a number of eucaryotic proteins, a large portion of small t produced in bacteria is found in an insoluble state. When bacteria expressing small t from pTR1330 are sonicated and insoluble proteins are collected by low-speed centrifugation, small t is the third most abundant protein in the pellet (Fig. 4A, lane 1) . We have devised a procedure to purify the small t from this pellet by selectively washing away other proteins. The optimal procedure is described in detail in Materials and Methods. The method results in the purification of small t to 80 to 90% homogeneity (Fig. 4A, lanes 2 to 4) . Our yields of small t from this procedure have routinely been in the range of 1 to 2 mg of small t per liter of bacterial culture.
This purification procedure has proved to be generally applicable and has been used in our laboratory to purify Py-1387T middle T (Fig. 4B ) and adenovirus ElA (D. Kimmelman, D. Pallas, and T. M. Roberts, unpublished data) expressed in the same cells. Py-1387T middle T is less abundant in the insoluble cell debris (Fig. 4B, lane 1) when compared with the abundance of small t (Fig. 4A, lane 1) . Quantities of Py-1387T middle T on the order of 100 tg can be obtained easily by using this procedure.
Rabbit antisera raised against purified bacterial small t. We obtained high titer rabbit antisera by using as the immunogen bacterial small t in SDS-polyacrylamide gel bands. Bacterial small t preparations purified through the wash step by using 1% NP-40 and ,B-mercaptoethanol (see Fig. 4A , lane 5) were preparatively electrophoresed. The small t band was excised and used to immunize three rabbits as described in Materials and Methods. In the characterization experiments that follow, the three antisera give identical results. As expected, the antisera precipitate all three polyomavirus T antigens from polyomavirus-infected cells (see Fig. 5 ). The rabbit antisera are more efficient than rat anti-T ascites for precipitation of the [35S]methionine-labeled T antigens. We wanted to determine whether the rabbit antisera would precipitate the middle T-associated tyrosine protein kinase activity, which can be assayed in vitro in immunoprecipitates by looking for the incorporation of [-y-32P]ATP into middle T or into exogenously added substrates such as enolase. Immunoprecipitates labeled in vitro with [y-32P]ATP show labeling of both the 56-and 58-kDa forms of middle T (Fig. 5) . However, the 32P/35S ratio is significantly greater for the rat anti-T ascites than for the rabbit antisera.
Mouse monoclonal antibodies raised against purified bacterial small t. By using bacterial small t as an immunogen, we have also obtained a series of mouse hybridoma clones stably producing monoclonal antibodies. Their immunoprecipitation specificities fall into four types as summarized in Table 1 . First, two monoclonal antibodies designated Fl and F4 immunoprecipitated all three T antigens from polyomavirus-infected 3T6 cells (Fig. 6A, lanes 4 and 5) . Second, one monoclonal antibody designated F7 immunoprecipitated small t and middle T but apparently not large T (Fig. 6A, lane  6) . Third, two monoclonal antibodies designated F2 and F8 appeared to be small t specific (Fig. 6A, lanes 9 and 10) . However, on longer exposures a small amount of a band comigrating with middle T was seen in immunoprecipitates with F8. No middle T was detected in immunoprecipitates with F2, though we cannot rule out the possibility that a small amount was precipitated by this antibody. Attempts at precipitating middle T with F2 and F8 in cells expressing only middle T have given similar results (data not shown). Finally, two monoclonal antibodies designated F3 and F5 surprisingly appear to have a higher affinity for large T and middle T than for small t (Fig. 6A, lanes 7 and 8) .
Although 35S-labeled middle T antigen is immunoprecipitated by five of the seven monoclonal antibodies, middle T-associated kinase activity in vitro, as measured by phosphorylation of middle T and enolase, is barely detectable in those immunoprecipitates ( Fig. 6B ; data not shown). Figure  6B shows polypeptides incorporating label in vitro when parallel immunoprecipitates of T antigens from polyomavirus-infected cells with the various antibodies are incubated with [-y-32PIATP. The phosphorylation of large T is seen in immunoprecipitates with either the rabbit antisera or monoclonal antibodies recognizing large T (lanes 3 to 5, 7, and 8). In contrast, labeling of middle T easily detected in immunoprecipitates with rabbit antisera (lane 3) cannot be seen in immunoprecipitates with the monoclonal antibodies. After long exposures, some radioactivity comigrating with middle T can be detected in immunoprecipitates with Fl, F4, or F5 (data not shown). Treatment of cell extracts with the monoclonal antibodies before immunoprecipitation with rat anti-T ascites does not result in inhibition of phosphorylation of middle T in vitro (data not shown).
Like polyomavirus, the related papovavirus SV40 encodes small and large T antigens of 17 and 95 kDa which share a common amino-terminal sequence but have unique carboxyterminal sequences. Since polyomavirus T antigens in the amino-terminal region, we tested each monoclonal antibody for its ability to immunoprecipitate SV40 T antigens from extracts of COS1 cells which produce both SV40 T antigens (Fig. 7) . Only F5 showed detectable crossreaction with SV40 proteins, and once again it seemed to bind preferentially to the large T antigen of SV40 rather than to the small t antigen (Fig. 7, lane 6 ). Using these antibodies, other investigators have found that both F3 and F5 give clear positive nuclear fluorescence on COS1 cells (H. Lorimer and C. Prives, unpublished data). DISCUSSION We have described the purification of milligram quantities of polyomavirus small t antigen and 100-,ug quantities of Py-1387T middle T antigen. The amount of these proteins obtained from bacteria was made possible in part by the introduction of a novel ribosome-binding site into former constructs for these proteins. Both this new site and the purification method described are equally useful for obtaining other bacterially expressed proteins. Polyclonal antibodies raised against the purified small t antigen were easily obtained and were consistently of high titer and affinity. Analysis of monoclonal antibodies raised against the small t antigen revealed structural differences among the three T antigens in the stretch of amino acids common to all three proteins. The lack of significant middle T-associated tyrosine kinase activity present in immunoprecipitates with the monoclonal antibodies that recognize the amino-terminal region of middle T is consistent with the idea that this region is important for the association of middle T with pp6Ocsrc.
The addition of the new ribosome-binding site presented here to the former construct for a T antigen-3-galactosidase fusion protein increased production of the protein 5-to 10-fold as measured by its accumulation over 3 h. The increase is likely due to the synthetic Shine-Dalgarno sequence, but it is possible that it resulted from the change in the spacer sequence lying between the Shine-Dalgarno sequence and the initiator codon (Fig. 1A) . This new ribosomebinding site has proven to be of general use in protein overproduction. To date, we and others have used it for the successful overproduction of pp60c-src (H. Piwnica-Worms and T. M. Roberts, unpublished data), v-rasH (14a), and recF (R. Kolodner, unpublished data).
Similarly, the procedure developed for the purification of small t from bacteria is of general value. Py-1387T middle T antigen and other proteins such as ElA of adenovirus and VP3 of polyomavirus (R. Garcea, unpublished data) can be purified by the same procedure. The method is rapid, achieves more than a 100-fold purification, and depends only on the fraction of the cloned protein present in an insoluble state. After being solubilized in a low percentage of SDS, the of them precipitated significant middle T-associated kinase activity. This is not due to some nonspecific inhibition of kinase activity; if used in conjunction with rat anti-T ascites, the monoclonal antibodies do not reduce the amount of 32p incorporation into middle T. Furthermore, the two monoclonal antibodies previously reported that recognize all three T antigens also failed to coimmunoprecipitate significant middle T-associated kinase activity although they precipitated the bulk of the middle T protein (12) . The simplest interpretation of these results is that most antibodies which recognize the amino terminus of middle T are directed against epitopes unavailable in the complex with pp6Oc-src.
The production of monoclonal antibodies which bind either all three T antigens (Fl, F4), small t and middle T only (F7), or primarily small t (F2, F8) was consistent with the known splicing pattern of the genes in the polyomavirus early region: small t shares 79 amino acids with both middle and large T antigens, shares an additional 112 amino acids only with middle T, and has 4 unique amino acids at its carboxyl terminus. However, the production of monoclonal antibodies preferring the middle and large T antigens over small t by using bacterially produced small t as immunogen was surprising. As described in Materials and Methods, these monoclonal antibodies were repeatedly screened during cloning and subcloning by using a radioimmunoassay for the bacterial small t immunogen. Thus, the F3 and F5 antibodies must recognize bacterial small t and to some extent small t from polyomavirus-infected cells (Fig. 6, lane  8) . The antigenic site (or sites) recognized by F3 and F5 must be present in the amino-terminal 79 amino acids common to all three polyomavirus T antigens, with the differential binding resulting from some change in the availability of the site. There are several possible explanations for this result. First, small t made during polyomavirus infection could be largely modified in a manner that masks or disrupts the epitope. No candidate modifications are currently known; however, biochemical investigations of the T antigens to date have not been extensive enough to rule out this possibility. Second, in animal cells there may be a protein associated with small t but not large or middle T at the site that these monoclonal antibodies recognize. The interaction between SV40 small t and host proteins has been reported (28, 33) . We are presently using our monoclonal antibodies that primarily bind small t as well as cell lines producing only polyomavirus small t (9) to search for cellular proteins that may associate with polyomavirus small t. Third, the common region of the T antigens may fold differently in small t, middle T, and large T, creating antigenic differences among these proteins in this region. The bacterial small t used as immunogen may be able to assume several different conformations, one mimicking animal cell small t and another mimicking large and middle T. Alternatively, F3 and F5 may be sequence-specific antibodies directed to a sequence exposed on native middle and large T and the partially denatured bacterial small t used as immunogen but not on native small t. A precedent for our results exists. Walter and colleagues have previously described a rabbit antiserum raised against a synthetic peptide corresponding to the common amino-terminal region of SV40 T antigens that immunoprecipitates the large T antigen but not the small T antigen of SV40 (44) . The specificities of F7, F2, and F8 could also be caused by factors other than the primary sequence of amino acids recognized. Further research is required to distinguish among these possibilities.
Two other points concerning the F3 and F5 antibodies should be noted. First, the epitopes recognized were con-
